GILD
$104.21
Revenue | $7569Mn |
Net Profits | $1783Mn |
Net Profit Margins | 23.56% |
Gilead Sciences Inc.’s revenue jumped 6.38% since last year same period to $7569Mn in the Q4 2024. On a quarterly growth basis, Gilead Sciences Inc. has generated 0.32% jump in its revenue since last 3-months.
Gilead Sciences Inc.’s net profit jumped 24.77% since last year same period to $1783Mn in the Q4 2024. On a quarterly growth basis, Gilead Sciences Inc. has generated 42.3% jump in its net profits since last 3-months.
Gilead Sciences Inc.’s net profit margin jumped 17.29% since last year same period to 23.56% in the Q4 2024. On a quarterly growth basis, Gilead Sciences Inc. has generated 41.85% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 1.77 |
EPS Estimate Current Year | 1.77 |
Gilead Sciences Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.77 - a 4.24% jump from last quarter’s estimates.
Gilead Sciences Inc.’s earning per share (EPS) estimates for the current year stand at 1.77.
Earning Per Share (EPS) | 1.81 |
Dividend Per Share (DPS) | 0.79 |
Gilead Sciences Inc.’s earning per share (EPS) jumped 237.12% since last year same period to 1.81 in the Q1 2025. This indicates that the Gilead Sciences Inc. has generated 237.12% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Gilead Sciences Inc. declared 0.79 dividend per share during the earnings announcement for Q1 2025.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-05-08 | 1.77 | 1.81 | 2.11% |